Therefore, our research aims to evaluate the application value of detecting the methylation status of SEPT9, SDC2, and ALX4 genes in cell‐free DNA from CRC patients, precancerous lesion patients, and healthy individuals. This evidence concerns the gene SDC2 and colorectal carcinoma.